Video Experimental Relacionado
Updated: Feb 5, 2026
07:49
Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
2.0K
Perfilado Proteómico a Gran Escala de Insuficiencia Cardíaca Incidente y sus Subtipos en Adultos Mayores
Joyce N Njoroge1, Sandra Sanders van Wijk2, Thomas R Austin3
1Division of Cardiology, Department of Medicine, Stanford University, Palo Alto, CA (J.N.N.).
Circulation. Genomic and precision medicine
|February 4, 2026
Resumen
Este estudio identificó 55 nuevos marcadores de proteínas para la insuficiencia cardíaca (IC) y sus subtipos en adultos mayores. Siete proteínas nuevas muestran posibles vínculos causales, lo que ofrece potencial para mejorar la predicción de riesgos y las dianas terapéuticas.
Área de la Ciencia:
- Ciencia Cardiovascular
- Proteómica
- Gerontología
Sus antecedentes:
- La insuficiencia cardíaca (IC), incluida la IC-FEp y la IC-FEi, afecta significativamente a la población de edad avanzada.
- La evaluación del proteoma circulante es crucial para comprender la patogénesis de la IC y desarrollar nuevos tratamientos.
Objetivo del estudio:
- Realizar un cribado proteómico de plasma para la IC incidente y sus subtipos en adultos mayores.
- Identificar biomarcadores proteicos novedosos asociados con IC, IC-FEp e IC-FEi.
- Investigar posibles relaciones causales entre proteínas y subtipos de IC utilizando aleatorización mendeliana.
Principales métodos:
- Cribado proteómico de plasma en dos cohortes grandes basadas en la población (CHS y AGES-RS) utilizando plataformas SomaLogic.
- Metaanálisis de modelos de Cox para identificar asociaciones de proteínas con IC, IC-FEp e IC-FEi.
- Replicación en la cohorte ARIC y aleatorización mendeliana para inferencia causal.
Principales resultados:
- Se identificaron 119 proteínas asociadas con IC, 15 con IC-FEp y 11 con IC-FEi.
- Se descubrieron 55 nuevos marcadores de proteínas para la IC o sus subtipos, y 7 mostraron posibles asociaciones causales.
- Se replicaron 55 de las 66 proteínas identificadas externamente.
Conclusiones:
- Este estudio proteómico a gran escala identificó nuevos marcadores de proteínas para la insuficiencia cardíaca en adultos mayores.
- Estos hallazgos pueden mejorar la predicción del riesgo de IC, la comprensión de la patobiología y la priorización de dianas terapéuticas.
- Siete proteínas demostraron asociaciones nuevas y posiblemente causales con subtipos de IC.
Videos de Conceptos Relacionados
01:29Heart Failure II: Pathophysiology
948
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
948
01:17Pathophysiology of Heart Failure
3.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
01:27Heart Failure I: Introduction
903
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
01:22Heart Failure VI: Adjunct Therapies
348
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
01:22Heart Failure Drugs: Diuretics
981
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
981
01:30Heart Failure V: Medical Management
329
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
329